Valeriana jatamansi (Valerian, Mushkbala) is a high value medicinal plant of Himalayan region especially India, China, Nepal and Pakistan. V. jatamansi is utilized for health benefits from many centuries and documented majorly in Indian, and Chinese System of Medicine. Continuous research on the development, adaptation, hydroxyl valerenic acid, acetoxyvalerenic acid, acevaltrate, didrovaltrate, valerenic acid, valtrate), a reproducible, stable UPLC-PDA method was developed and validated as per ICH guidelines. The validated method revealed the presence of valepotriate that includes valtrate as most abundant valepotriate, followed by didrovaltrate and acevaltrate among the different samples of V. jatamansi . Further, development of V. jatamansi extract-loaded nanosponges demonstrates the potential of nanotechnology in enhancing the stability and delivery of plant-based therapeutics. Current research revealed organ specific chemogeographical variation qualitative and quantitative variations of V. jatamansi samples. These findings highlighted the potential of V. jatamansi and suggested the direction towards the conservation strategies for quality produce of future benefits.
Rawat et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: